Csl Ltd ADR (CSLLY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CSLLY | REGN | ALNY | ||
| Company | Csl Ltd ADR | Regeneron Pharmaceuticals | Alnylam Pharmaceuticals | ||
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | ||
| Open | 58.3300 | 811.00 | 376.50 | ||
| High | 58.5400 | 811.00 | 376.50 | ||
| Low | 58.2500 | 811.00 | 376.50 | ||
| Latest | 58.5300 | 798.11 | 369.17 | ||
| Change | -0.2500 | +1.56 | -29.12 | ||
| % Change | -0.43% | +0.20% | -7.31% | ||
| Volume | 86,900 | 6,418 | 17,105 | ||
| 20-Day Average Volume | 150,325 | 769,986 | 1,605,435 | ||
| Previous Close | 58.7800 | 796.55 | 398.29 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 58.5085 | 775.16 | 398.56 | ||
| 20-Day Raw Stochastic | 46.40% | 88.34% | 0.00% | ||
| 20-Day Relative Strength | 46.26 | 65.22 | 36.68 | ||
| Weighted Alpha | -34.66 | +35.42 | +36.56 | ||
| Today's Opinion | 88% Sell | 100% Buy | 24% Sell | ||
| Previous Opinion | 72% Sell | 100% Buy | 24% Sell | ||
| Last Month's Opinion | 88% Sell | 88% Buy | 24% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.77% since 01/02/26 | +6.26% since 01/05/26 | -5.36% since 01/05/26 | ||
| Low | 55.3600 on 01/06/26 | 763.20 on 01/06/26 | 376.50 on 01/12/26 | ||
| High | 58.7900 on 01/08/26 | 821.11 on 01/09/26 | 427.05 on 01/07/26 | ||
| 1-Month | |||||
| %Chg | -3.95% since 12/09/25 | +9.40% since 12/12/25 | -5.29% since 12/12/25 | ||
| Low | 55.3600 on 01/06/26 | 734.72 on 12/16/25 | 376.50 on 01/12/26 | ||
| High | 62.1918 on 12/12/25 | 821.11 on 01/09/26 | 427.05 on 01/07/26 | ||
| 3-Month | |||||
| %Chg | -13.76% since 10/09/25 | +43.63% since 10/10/25 | -18.23% since 10/10/25 | ||
| Low | 54.1000 on 10/29/25 | 541.00 on 10/13/25 | 376.50 on 01/12/26 | ||
| High | 72.5700 on 10/22/25 | 821.11 on 01/09/26 | 495.55 on 10/20/25 | ||
| 6-Month | |||||
| %Chg | -26.97% since 07/09/25 | +42.85% since 07/11/25 | +19.55% since 07/11/25 | ||
| Low | 54.1000 on 10/29/25 | 541.00 on 10/13/25 | 309.57 on 07/15/25 | ||
| High | 89.7100 on 07/29/25 | 821.11 on 01/09/26 | 495.55 on 10/20/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 56,791,832 | 83,716,600 | 52,619,680 | ||
| Shares Outstanding, K | 970,303 | 105,099 | 132,114 | ||
| Annual Sales | 15,558,000,000 | 14,202,000,000 | 2,248,240,000 | ||
| Annual Net Income | 3,002,000,000 | 4,412,600,000 | -278,160,000 | ||
| Last Quarter Sales | N/A | 3,754,300,000 | 1,249,030,000 | ||
| Last Quarter Net Income | N/A | 1,460,000,000 | 251,080,000 | ||
| 60-Month Beta | 0.77 | 0.39 | 0.32 | ||
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 11.83 on 10/28/25 | 2.90 on 10/30/25 | ||
| Latest Earnings Date | 01/01/70 | 01/30/26 | 02/12/26 | ||
| Most Recent Dividend | 0.760 on 09/10/25 | 0.880 on 11/20/25 | N/A | ||
| Next Ex-Dividends Date | 09/10/25 | 11/20/25 | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 21.72 | 1,731.70 | ||